We’re proud to announce that for the second year running we were named one of the top 100 companies in Modern Healthcare’s 100 Best Places to Work in Healthcare. As the healthcare industry continues to grow, it’s an honor to be recognized. This award represents top companies that empower their employees to provide patients and customers with the best possible care, products and services.
Since receiving this recognition in 2014, MedeAnalytics has grown to nearly 350 employees, providing analytics solutions to the healthcare market. We are continuing our strong business momentum in the midst of our third consecutive year of greater than 30% growth, while also expanding with the acquisition of OnFocus Healthcare. In addition, the company has continued to expand operations in Richardson, Texas with future plans for expansion of our Emeryville headquarters.
It’s the hard work and commitment from our employees that have contributed to our company growth and the delivery of innovative solutions that help our customers improve care while managing their costs, quality, revenue and risk.
If you are interested in becoming part of the MedeAnalytics team, please visit our career page: https://medeanalytics.com/company/careers.
Get our take on industry trends
MedeAnalytics at HIMSS26: Turning Insight into Measurable Healthcare Performance
March 9-12, 2026 | Venetian Convention & Expo Center | Las Vegas As margin pressure intensifies and value-based care…
Read on...Turning social risk into measurable financial performance
Payers increasingly recognize that social risk factors materially influence total cost of care, utilization, and quality performance. Yet for many…
Read on...The GLP-1 Insights Series, Part 2: Maximizing impact and savings through analytics
GLP-1s present a major opportunity for organizations to improve clinical outcomes and reduce long-term healthcare costs. However, payers and providers…
Read on...The GLP-1 Insights Series, Part 1: Long-term impact on costs and outcomes for payers and providers
Few pharmaceuticals have surged in popularity as fast as GLP-1s. This growth is well-justified. GLP-1s, a class of medications originally…
Read on...